Posted by Clinical Lab Products | May 26, 2011 | Cancer, Miscellaneous, Webcasts |
Some argue that there is not enough evidence to suggest PSA’s use as a screening tool improves patient survival, but others believe the test has been instrumental in reducing mortality from prostate cancer in the US.
Read MorePosted by Clinical Lab Products | Mar 13, 2011 | Cancer, Miscellaneous |
Targeting CDK2/cyclin E with Cyclacel’s CYC065 reportedly overcomes Herceptin resistance in HER2-positive breast cancer.
Read MorePosted by Clinical Lab Products | Sep 16, 2010 | Cancer, Miscellaneous |
Med BioGene Inc announced the publication of a study detailing the development and validation of the 15-gene signature used by LungExpress Dx entitled “Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small-Cell Lung Cancer”.
Read MorePosted by Clinical Lab Products | Jul 12, 2010 | Cancer, Miscellaneous |
Researchers at the University of Cincinnati (UC) and Cincinnati Children’s Hospital Medical Center have found that a certain blood test can successfully identify lymphangioleiomyomatosis (LAM) in some patients, eliminating the need for surgical lung biopsy to make a diagnosis.
Read MorePosted by Clinical Lab Products | Mar 30, 2010 | Cancer, Miscellaneous |
Tumors biopsied from women with invasive breast cancer are having their genomes sequenced in an attempt to develop a DNA profile that one day may identify ahead of time the patients who will most likely respond to chemotherapy with an aromatase inhibitor.
Read More